Literature DB >> 1510986

Incision at O6-methylguanine:thymine mispairs in DNA by extracts of human cells.

R S Day.   

Abstract

Human cell-free extracts were used to detect activities specifically incising O6-methylguanine (m6G) paired with C or T in DNA. A 45-bp double-stranded DNA containing one m6G across from a T (m6G:T) was the test substrate. Extracts from glioblastoma cell lines A172 and A1235 (lacking the m6G-specific repair protein m6G-DNA methyltransferase, MGMT) and colon carcinoma cell line HT29, containing MGMT, showed incision activities specific for the T strand of m6G:T [and G:T, as reported previously by Wiebauer and Jiricny (1989)] substrates, but did not cleave m6G:C (or G:C) substrates. Competition experiments showed that the activity was similar to, if not identical with, the activity in human cells that incises G:T mismatches. The incision sites were similar to those recognized by human G:T- or G:A-specific mismatch enzymes, i.e., the phosphodiester bonds both 3' and 5' to the poorly matched T, suggesting the glycolytic removal of the poorly matched T followed by backbone incisions by class I or II AP endonucleases. Three experiments in which MGMT was inactivated showed that the m6G:T incision activity was not simply due to a two-step mechanisms in which MGMT would first mediate conversion of the m6G:T substrate to a G:T substrate which would serve as a substrate for G:T incision. Extracts from HT29 contained a DNA-binding factor, possibly DNA sequence-specific, that inhibited incision of the m6G:T (but not the G:T) substrate, that was removed by the addition of synthetic DNA to the reaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1510986     DOI: 10.1021/bi00149a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Minimally cytotoxic doses of temozolomide produce radiosensitization in human glioblastoma cells regardless of MGMT expression.

Authors:  Michael S Bobola; Douglas D Kolstoe; A Blank; John R Silber
Journal:  Mol Cancer Ther       Date:  2010-05       Impact factor: 6.261

Review 2.  Direct reversal of DNA alkylation damage.

Authors:  Yukiko Mishina; Erica M Duguid; Chuan He
Journal:  Chem Rev       Date:  2006-02       Impact factor: 60.622

3.  Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

Authors:  Jill A Maxwell; Stewart P Johnson; Roger E McLendon; David W Lister; Krystle S Horne; Ahmed Rasheed; Jennifer A Quinn; Francis Ali-Osman; Allan H Friedman; Paul L Modrich; Darell D Bigner; Henry S Friedman
Journal:  Clin Cancer Res       Date:  2008-08-01       Impact factor: 12.531

4.  Recognition of DNA alterations by the mismatch repair system.

Authors:  G Marra; P Schär
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

5.  DNA-substrate sequence specificity of human G:T mismatch repair activity.

Authors:  R S Day
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

6.  Initiation of strand incision at G:T and O(6)-methylguanine:T base mismatches in DNA by human cell extracts.

Authors:  S U Lari; R S Day; K Dobler; M C Paterson
Journal:  Nucleic Acids Res       Date:  2001-06-01       Impact factor: 16.971

7.  Repair of O6-alkylguanines in the nuclear DNA of human lymphocytes and leukaemic cells: analysis at the single-cell level.

Authors:  J Thomale; F Seiler; M R Müller; S Seeber; M F Rajewsky
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

8.  Metal-dependent conformational activation explains highly promutagenic replication across O6-methylguanine by human DNA polymerase β.

Authors:  Myong-Chul Koag; Seongmin Lee
Journal:  J Am Chem Soc       Date:  2014-04-02       Impact factor: 15.419

9.  The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.

Authors:  Claudio Festuccia; Andrea Mancini; Alessandro Colapietro; Giovanni Luca Gravina; Flora Vitale; Francesco Marampon; Simona Delle Monache; Simona Pompili; Loredana Cristiano; Antonella Vetuschi; Vincenzo Tombolini; Yi Chen; Thomas Mehrling
Journal:  J Hematol Oncol       Date:  2018-02-27       Impact factor: 17.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.